ArticleLife (Basel, Switzerland)2026
Subjective and Objective Stress in Inflammatory Bowel Disease.
Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundStress may have an impact on the course of inflammatory bowel disease (IBD), but evidence is still lacking regarding a potential association between perceived (subjective) stress and objectively measured stress and whether patients' levels of stress in relapse differ from those in remission. The aim of this study was to investigate patients' level of stress in relapse and in remission.
methodsTwenty-three patients with active IBD participated in the study. Cortisol was assessed in saliva and in blood to obtain objective measurements. For subjective measurements, the patients completed the Short Health Scale (SHS) and Perceived Stress Scale (PSS) questionnaires. Physiological measurements were taken, and questionnaires were completed at the beginning of relapse and when the patient was classified as being in remission. Relapses and remissions were determined by endoscopic examination and faecal calprotectin.
resultsCortisol levels did not differ between measurements in active disease and in remission (7.50 ± 5.52 vs. 5.55 ± 2.65). PSS showed no differences between the two measurements (13 vs. 16,
conclusionsThis study demonstrated low to moderate levels of perceived stress in patients with IBD during active disease and remission. The results also showed significantly elevated levels of the pro-inflammatory cytokines IL-6 and IL-8 in serum during relapse compared with remission. However, no evidence of elevated objective stress was found when levels of cortisol in saliva were measured. Further research is needed to establish the possible association between stress and IBD and how it affects patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.